Biomarin Pharmaceutical: Q3 Earnings Insights

Biomarin Pharmaceutical BMRN reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Biomarin Pharmaceutical beat their estimated earnings by 20.0%, reporting an EPS of $-0.2 versus an estimate of $-0.25, which surprised analysts.

Revenue was up $68,042,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.18, which was followed by a 0.28% drop in the share price the next day.

Here's a look at Biomarin Pharmaceutical's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.